0

CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER از شرکت B BRAUN

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER از شرکت B BRAUN

New Drug Application (NDA): 050792

Company: B BRAUN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER CEFOTAXIME SODIUM EQ 2GM BASE INJECTABLE;INJECTION Discontinued

None

No No
CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER CEFOTAXIME SODIUM EQ 1GM BASE INJECTABLE;INJECTION Discontinued

None

No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/29/2004 ORIG-1 Approval

Type 5 – New Formulation or New Manufacturer

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50792lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50792ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/050792s000_Duplex_ContainerTOC.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/10/2007 SUPPL-2 Labeling

Label (PDF)

Letter (PDF)

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050792s002lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/050792s002ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
09/10/2007 SUPPL-2

Labeling

Label (PDF)

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050792s002lbl.pdf
07/29/2004 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50792lbl.pdf

نظرات کاربران